Flow Pharma is dedicated to immunotherapy innovation.
Our exclusive technology and manufacturing expertise are poised to transform the treatment and prevention of cancer and viral disease.
An inhaled treatment to prevent COVID-19 disease in both virus-exposed and healthy patient populations.
FlowVax Ebola & Marburg
Marburg is a weaponized Ebola-like virus. By stimulating T-cells to target this virus, long-lasting infection prevention is attainable.
A revolutionary T-cell biomedicine that provides new hope for those with treatment-resistant, triple-negative breast cancer.